Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.40% | 39.94% | 78.61% | 37.62% | 5.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.40% | 39.94% | 78.61% | 37.62% | 5.66% |
| Cost of Revenue | 3.35% | 22.02% | 44.95% | 11.52% | -12.34% |
| Gross Profit | 17.00% | 53.37% | 106.48% | 61.36% | 23.27% |
| SG&A Expenses | 14.01% | 9.22% | 4.42% | 1.60% | -1.18% |
| Depreciation & Amortization | -4.57% | -7.75% | -10.54% | -20.05% | -27.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.95% | 9.68% | 10.44% | -0.19% | -9.53% |
| Operating Income | -5.38% | 23.38% | 45.30% | 35.14% | 25.17% |
| Income Before Tax | 16.40% | 30.13% | 43.50% | 23.70% | 4.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.40% | 30.13% | 43.50% | 23.70% | 4.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.40% | 30.13% | 43.50% | 23.70% | 4.22% |
| EBIT | -5.38% | 23.38% | 45.30% | 35.14% | 25.17% |
| EBITDA | -6.59% | 28.76% | 54.05% | 38.31% | 21.58% |
| EPS Basic | 45.26% | 53.99% | 61.02% | 55.94% | 52.97% |
| Normalized Basic EPS | 45.76% | 62.26% | 72.00% | 64.49% | 59.31% |
| EPS Diluted | 45.26% | 53.99% | 61.02% | 55.94% | 53.09% |
| Normalized Diluted EPS | 45.76% | 62.26% | 72.00% | 64.49% | 59.31% |
| Average Basic Shares Outstanding | 46.85% | 50.57% | 55.48% | 72.19% | 97.24% |
| Average Diluted Shares Outstanding | 46.85% | 50.57% | 55.48% | 72.19% | 97.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |